- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07547566
Recupero post-affaticamento nei giovani atleti: confronto tra terapia TECAR e cicloergometro
Effetti immediati e a breve termine della terapia TECAR e dell'ergometro da ciclo sul recupero dopo affaticamento in giovani atleti: uno studio randomizzato controllato
The goal of this clinical trial is to compare two recovery methods after fatigue in young athletes. It aims to find out if tecar therapy (TECAR) or cycle ergometer exercise can improve recovery after intense physical activity and help athletes return to their normal performance more quickly.
The main questions it aims to answer are:
Does TECAR or cycle ergometer improve physical performance after fatigue?
Do these methods reduce muscle pain and soreness after fatigue?
Researchers will compare TECAR with active recovery using a cycle ergometer to see which method is more effective.
Participants will:
Perform a series of jumps to induce fatigue
Be randomly assigned to one of the recovery methods
Complete physical tests before and after fatigue
Undergo simple measurements of muscle condition and pain
Report their level of effort and muscle soreness
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This study is a randomized controlled trial designed to evaluate and compare the effectiveness of two recovery strategies following exercise-induced fatigue in young athletes: tecar therapy (TECAR) and active recovery (usual care) using a cycle ergometer.
Exercise-induced fatigue can reduce physical performance and increase muscle soreness, which may negatively affect athletic performance and increase injury risk. This study aims to compare the effects of two commonly used recovery strategies on physical performance, muscle mechanical properties, and perceived recovery.
Participants will be physically active young athletes over 18 years of age, familiar with plyometric or jump-based activities. They will be recruited through convenience sampling. Individuals with recent musculoskeletal injuries or those who have performed intense physical exercise within 24 hours prior to testing will be excluded.
All procedures will be conducted in a controlled environment by trained personnel following a standardized protocol. After providing informed consent, participants will undergo baseline assessments, including physical performance tests, measurements of muscle mechanical properties, and subjective perception of effort and muscle soreness.
A standardized warm-up will be performed prior to testing, consisting of low-intensity aerobic activity for approximately five minutes, aiming to reach a moderate level of perceived exertion.
Participants will then complete a fatigue protocol consisting of repeated drop jumps from a fixed height of approximately 0.6 meters. The protocol will be organized into multiple sets with controlled rest intervals between repetitions and sets in order to induce acute neuromuscular fatigue in a standardized manner.
Immediately after the fatigue protocol, the same assessments will be repeated to evaluate the acute effects of fatigue.
Participants will then be randomly assigned to one of the two recovery interventions:
TECAR: application of capacitive and resistive electric transfer using radiofrequency energy for 20 minutes
Active recovery (usual care): continuous cycling on a cycle ergometer at low-to-moderate intensity for 20 minutes, reflecting standard recovery practices commonly used in athletic settings
Following the assigned recovery intervention, all assessments will be repeated to evaluate recovery effects.
In addition, subjective measures of muscle soreness and perceived effort will be collected at 12 and 24 hours after the intervention to assess short-term recovery.
Outcome measures will include objective indicators of physical performance and muscle mechanical properties, assessed using a handheld myotonometer, as well as pressure pain threshold (a measure of sensitivity to pressure), and subjective measures related to perceived effort and muscle soreness.
Statistical analysis will include descriptive statistics and inferential analysis to compare differences between groups and over time. A two-way analysis of variance (group × time) will be used to evaluate the effects of the recovery intervention and measurement time points, including potential interaction effects. Statistical significance will be set at p < 0.05.
This study aims to provide evidence on the comparative effectiveness of TECAR and active recovery strategies, contributing to the optimization of recovery protocols in athletic populations.
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Sandra Alcaraz Clariana, PhD PT
- Numero di telefono: +34625434043
- Email: m72alcls@uco.es
Backup dei contatti dello studio
- Nome: Lourdes García Luque, PhD PT
- Numero di telefono: +34627366324
- Email: z12galul@uco.es
Luoghi di studio
-
-
Córdoba
-
Córdoba, Córdoba, Spagna, 14011
- Reclutamento
- Physiobalance
-
Contatto:
- Sandra Alcaraz Clariana, PhD PT
- Numero di telefono: +34625434043
- Email: m72alcls@uco.es
-
Contatto:
- Lourdes García Luque, PhD PT
- Numero di telefono: +34627366324
- Email: z12galul@uco.es
-
Investigatore principale:
- Sandra Alcaraz Clariana, PhD PT
-
Sub-investigatore:
- Lourdes García Luque, PhD PT
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Adults aged 18 years or older
- Engaging in regular physical activity
- Experience with sports involving jumping or plyometric exercises
Exclusion Criteria:
- Performed intense physical exercise within 24 hours before the study
- Planned to perform intense physical exercise within 24 hours after the study
- Presence of muscle soreness at the beginning of the study
- Musculoskeletal injury in the previous 6 months
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: TECAR
Participants assigned to this group will receive tecar therapy (TECAR) for 20 minutes. TECAR will be applied using the capacitive mode only, combining manual mobile application and fixed automatic application. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants. |
TECAR is applied using capacitive radiofrequency energy for 20 minutes following a standardized fatigue protocol. The intervention is delivered using capacitive mode only, combining manual mobile application and fixed automatic application over the quadriceps region to promote recovery after exercise-induced fatigue.
Altri nomi:
|
|
Comparatore attivo: Active recovery (usual care)
Participants assigned to this group will perform active recovery (usual care) consisting of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. The intervention will be applied after a standardized fatigue protocol consisting of repeated drop jumps, which is identical for all participants. This intervention reflects standard recovery practices commonly used in athletic settings. |
Active recovery consists of continuous cycling on a cycle ergometer for 20 minutes at low intensity, not exceeding 2-3 on a 0-10 rating of perceived exertion scale. This intervention is performed after a standardized fatigue protocol and reflects common recovery practices in athletic settings.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Countermovement jump height
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
Vertical jump performance will be assessed using a countermovement jump test. Jump height will be measured using a validated mobile application after three attempts, and the mean value will be recorded. |
Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Muscle mechanical properties
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
Muscle mechanical properties will be assessed using a handheld myotonometer. Parameters will include muscle tone and stiffness measured at standardized anatomical locations of the rectus femoris, vastus lateralis, medial gastrocnemius, and lateral gastrocnemius. |
Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
|
Pressure pain threshold
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
Pressure pain threshold will be assessed using a handheld algometer. Measurements will be performed at standardized anatomical locations of the rectus femoris, vastus lateralis, and medial gastrocnemius, and the mean of repeated measurements will be recorded. |
Baseline (after warm-up), immediately after fatigue protocol, and immediately after intervention (20 minutes).
|
|
Rating of perceived exertion
Lasso di tempo: Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.
|
Perceived exertion will be assessed using a 0-10 rating scale, where higher values indicate greater perceived effort. |
Baseline (after warm-up), immediately after fatigue protocol, immediately after intervention (20 minutes), 12 hours, and 24 hours.
|
|
Delayed-onset muscle soreness.
Lasso di tempo: Baseline (after warm-up), 12 hours, and 24 hours.
|
Delayed-onset muscle soreness (DOMS) will be assessed using a 0-10 numeric rating scale, where 0 indicates no muscle soreness and 10 indicates the worst possible muscle soreness. |
Baseline (after warm-up), 12 hours, and 24 hours.
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Sandra Alcaraz Clariana, PhD PT, Maimonides Biomedical Research Institute of Cordoba (IMIBIC). Department of Nursing, Pharmacology and Physical Therapy, Faculty of Medicine and Nursing, University of Córdoba, Córdoba, Spain;
Pubblicazioni e link utili
Pubblicazioni generali
- Dupuy O, Douzi W, Theurot D, Bosquet L, Dugue B. An Evidence-Based Approach for Choosing Post-exercise Recovery Techniques to Reduce Markers of Muscle Damage, Soreness, Fatigue, and Inflammation: A Systematic Review With Meta-Analysis. Front Physiol. 2018 Apr 26;9:403. doi: 10.3389/fphys.2018.00403. eCollection 2018.
- Lettner J, Graventein L, Hakam HT, Ramadanov N, Becker R, Prill R. Assessment of Muscle Stiffness Using the MyotonPro: Effects of Fatigue on Vastus Lateralis and Medialis Muscles. J Pers Med. 2024 Mar 12;14(3):301. doi: 10.3390/jpm14030301.
- Nakamura M, Sato S, Kiyono R, Yahata K, Yoshida R, Kasahara K, Konrad A. The Effect of Capacitive and Resistive Electric Transfer Intervention on Delayed-Onset Muscle Soreness Induced by Eccentric Exercise. Int J Environ Res Public Health. 2022 May 8;19(9):5723. doi: 10.3390/ijerph19095723.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MGC24
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .